A
Alaunos Therapeutics, Inc. (TCRT)
NCM – Real vaqt narxi. Valyuta: USD
2.08
+0.01 (0.48%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.41
+0.33 (15.87%)
Bozordan keyin: Jun 26, 2026, 7:38 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
2.08
+0.01 (0.48%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
2.41
+0.33 (15.87%)
Bozordan keyin: Jun 26, 2026, 7:38 PM EDT
Alaunos Therapeutics, Inc. — bu preclinical bosqichdagi biofarmatsevtika kompaniyasi bo'lib, semirish va unga bog'liq metabolik kasalliklarni davolash uchun og'iz orqali yuboriladigan kichik molekulali terapevtik vositalarni ishlab chiqadi. Kompaniya gormonal bo'lmagan, inkretin bo'lmagan yondashuvni ishlab chiqadi va GLP-1 dorilari kabi gormonlarga asoslangan davolash usullaridan farqli o'laroq. Kompaniya, shuningdek, haydovchi mutatsiyalarni maqsad qilish uchun hunTR TCR kashfiyot platformasini ishlab chiqadi. Alaunos Therapeutics, Inc. 2003-yilda tashkil etilgan va Fort-Lauderdale, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Ferdinand Groenewald | Vice President of Finance & Corporate Secretary |
| Mr. Holger Weis CPA | Chairman of the Board & CEO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-26 | 8-K | tcrt-20260526.htm |
| 2026-05-18 | 8-K | tcrt-20260302.htm |
| 2026-05-15 | 10-Q | tcrt-20260331.htm |
| 2026-04-30 | 10-K/A | tcrt-20251231.htm |
| 2026-04-15 | 8-K | tcrt-20260409.htm |
| 2026-03-31 | 10-K | tcrt-20251231.htm |
| 2026-03-02 | 8-K | tcrt-20260302.htm |
| 2026-01-08 | 8-K | tcrt-20260108.htm |
| 2025-12-23 | 8-K | tcrt-20251217.htm |
| 2025-11-14 | 10-Q | tcrt-20250930.htm |